# Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease

> **NCT00221026** · PHASE2 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 25 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Methoxsalen +ECP
- **PROCEDURE:** Extracorporeal Photopheresis

## Key facts

- **NCT ID:** NCT00221026
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221026, "Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00221026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*